Vericel Corp
VCELNasdaqCIK 887359HealthcareFiscal year ends Dec 31
Reports and events: 341 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-07-3008:49 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-050836 |
| 2026-07-3008:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-050815 |
| 2026-05-1816:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-26-021892 |
| 2026-05-0708:54 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-031742 |
| 2026-05-0707:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-031713 |
| 2026-05-0116:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-26-018538 |
| 2026-03-1907:30 ET | DEF 14A | Proxy statementPeriod 2026-04-29 | 0001308179-26-000094 |
| 2026-02-2609:00 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-012013 |
| 2026-02-2608:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-012003 |
| 2026-01-1309:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-001060 |
| 2025-11-0608:47 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-049902 |
| 2025-11-0608:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-049880 |
| 2025-07-3108:50 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-036859 |
| 2025-07-3108:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-036854 |
| 2025-05-0808:53 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-023496 |
| 2025-05-0808:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-023481 |
| 2025-05-0216:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-25-017110 |
| 2025-04-1407:55 ET | 8-K | 7.01 Regulation FD disclosure | 0001140361-25-013625 |
| 2025-03-2007:30 ET | DEF 14A | Proxy statementPeriod 2025-04-30 | 0001308179-25-000169 |
| 2025-02-2708:57 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-008447 |
| 2025-02-2708:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-008444 |
| 2025-01-1416:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-001060 |
| 2024-11-0708:48 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-046015 |
| 2024-11-0708:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-045997 |
| 2024-08-2608:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-038472 |
| 2024-08-1516:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-037511 |
| 2024-08-0109:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-033905 |
| 2024-08-0108:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-033894 |
| 2024-05-0808:59 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-021399 |
| 2024-05-0808:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-021382 |
| 2024-05-0316:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-24-024327 |
| 2024-03-2107:30 ET | DEF 14A | Proxy statementPeriod 2024-05-01 | 0001308179-24-000206 |
| 2024-02-2909:04 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-007824 |
| 2024-02-2908:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-007807 |
| 2024-01-0916:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-001518 |
| 2023-11-0809:11 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001628280-23-037583 |
| 2023-11-0808:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-037567 |
| 2023-09-2016:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-102314 |
| 2023-08-0208:47 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001628280-23-026596 |
| 2023-08-0208:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-026579 |
| 2023-05-1008:49 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001628280-23-017039 |
| 2023-05-1008:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-017028 |
| 2023-05-0516:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-23-023201 |
| 2023-03-2308:00 ET | DEF 14A | Proxy statement | 0001308179-23-000307 |
| 2023-02-2309:03 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001628280-23-004714 |
| 2023-02-2308:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-004701 |
| 2023-01-1016:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-002721 |
| 2022-12-2916:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-130934 |
| 2022-11-0908:52 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001628280-22-029082 |
| 2022-11-0908:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-029065 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:59 ET. Listed shows no prices and gives no investment advice.